Stoke Therapeutics, Inc.
Pharmaceutical Preparations · Bedford, MA, United States
- PrincipalsBarry TichoCHIEF MEDICAL OFFICERIan F SmithChief Executive OfficerJason HoittChief Patient Officerand 6 more
- CompanyStoke Therapeutics, Inc.Bedford, MA, United States
- Phone line+1 (781) 430-8200General business
Stoke Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker STOK) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 9
Chief executive
Ian F SmithChief Executive Officer
Chair & board
Adrian R. KrainerDirector (Board)
Arthur A LevinDirector (Board)
Arthur TzianabosInterim Executive Chair
Edward M. MD KayeDirector (Board)
Finance
Thomas LeggettChief Financial Officer
Legal
Jonathan AllanGENERAL COUNSEL & CORP SEC
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Barry Ticho — CHIEF MEDICAL OFFICER
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Jason Hoitt — Chief Patient Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Thomas Leggett — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Ian F Smith — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Jazz Pharmaceuticals plcPharmaceutical Preparations · Dublin1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityRoivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityAmarin Corp PLC\UKPharmaceutical Preparations · Dublin 21 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capability